Single-Agent Rituximab for Primary CNS Lymphoma During Pregnancy As a Bridge to Definitive Management

被引：12
|
作者：
Burnette, Brian L. [1 ]
Jentoft, Mark A. [1 ]
Porrata, Luis F. [1 ]
Boyce, Thomas G. [1 ]
Witzig, Thomas E. [1 ]
机构：
[1] Mayo Clin, Rochester, MN 55905 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 07期
关键词：
DEFERRED RADIOTHERAPY; BREAST-CANCER; CHEMOTHERAPY; METHOTREXATE;
D O I：
10.1200/JCO.2012.47.6994
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：E14 / E17
页数：4
相关论文
共 50 条
  • [1] Intravascular lymphoma: a role for single-agent rituximab
    Bazhenova, L
    Higginbottom, P
    Mason, J
    LEUKEMIA & LYMPHOMA, 2006, 47 (02) : 337 - 341
  • [2] Rituximab in indolent lymphoma:: The single-agent pivotal trial
    McLaughlin, P
    Hagemeister, FB
    Grillo-López, AJ
    SEMINARS IN ONCOLOGY, 1999, 26 (05) : 79 - 87
  • [3] Dramatic response to single-agent rituximab in a patient with intravascular lymphoma
    Vrindavanam, Nandagopal
    Hamadani, Mehdi
    Steele, Barbara
    Awan, Farrukh
    Suster, Saul
    Benson, Don M., Jr.
    AMERICAN JOURNAL OF HEMATOLOGY, 2007, 82 (12) : 1120 - 1121
  • [4] Updated results of single-agent ibrutinib in recurrent/refractory primary (PCNSL) and secondary CNS lymphoma (SCNSL).
    Grommes, Christian
    Gavrilovic, Igor T.
    Kaley, Thomas Joseph
    Nolan, Craig
    Omuro, Antonio Marcilio Padula
    Wolfe, Julia
    Pentsova, Elena
    Hatzoglou, Vaios
    Mellinghoff, Ingo K.
    DeAngelis, Lisa Marie
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [5] Phase II multicenter study of brief single-agent methotrexate followed by irradiation in primary CNS lymphoma
    O'Brien, P
    Roos, D
    Pratt, G
    Liew, K
    Barton, M
    Poulsen, M
    Olver, I
    Trotter, G
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (03) : 519 - 526
  • [6] Efficacy and Safety of Frontline Single-Agent Rituximab in Extranodal Marginal Zone Lymphoma
    Mazzoni, Camilla
    Argnani, Lisa
    Casadei, Beatrice
    Broccoli, Alessandro
    Gabrielli, Giulia
    Fabbri, Nicole
    Gugliotta, Gabriele
    Pellegrini, Cinzia
    Carella, Matteo
    Bagnato, Gianmarco
    Gentilini, Marianna
    Morigi, Alice
    Maglio, Pierluca
    Cantelli, Martina
    Stefoni, Vittorio
    Zinzani, Pier Luigi
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2025, 114 (01) : 70 - 78
  • [7] Review of rituximab in primary CNS lymphoma
    Singh, Pawan K.
    Pan, Edward
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2020, 410
  • [8] Evaluation of treatment response with PERCIST in follicular lymphoma receiving rituximab single-agent immunotherapy
    Tatsumi, Mitsuaki
    Watabe, Tadashi
    Kato, Hiroki
    Imaizumi, Masao
    Shimosegawa, Eku
    Hatazawa, Jun
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [9] Rituximab as Single Agent in Primary MALT Lymphoma of the Ocular Adnexa
    Annibali, Ombretta
    Chiodi, Francesca
    Sarlo, Chiara
    Cortes, Magdalena
    Quaranta-Leoni, FrancescoM.
    Quattrocchi, Carlo
    Bianchi, Antonella
    Bonini, Stefano
    Avvisati, Giuseppe
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [10] Complete clinical response with single-agent high dose Rituximab in mantle cell lymphoma.
    Jain, D
    Dutcher, JP
    Wiernik, PH
    BLOOD, 2003, 102 (11) : 305B - 305B
12345